How much dividend does OncoCyte pay?
Over the past 12 months, OncoCyte paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OncoCyte is expected to pay a dividend of 0 USD.
OncoCyte Dividend 2024
OncoCyte Dividend
0 USD
OncoCyte Dividend yield
Ticker
OCX
ISIN
US68235C1071
WKN
A2ACBH
How much dividend does OncoCyte 2024 pay?
According to the latest status from June 2024, OncoCyte paid a total of 0 USD per share in dividends within the last 12 months. With the current OncoCyte price of 2.95 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical OncoCyte Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Is the OncoCyte Dividend Safe?
OncoCyte has been increasing the dividend for 0 years.
Over the past 10 years, OncoCyte has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding OncoCyte's Dividend Distributions
OncoCyte’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining OncoCyte's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
OncoCyte's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in OncoCyte’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
OncoCyte Aktienanalyse
What does OncoCyte do?
OncoCyte Corp is a company based in Alameda, California, that is involved in the field of cancer diagnostics. It was founded in 2009 with the goal of developing and commercializing innovative solutions for cancer diagnosis. The business model of OncoCyte Corp is based on the development and marketing of diagnostic tests for various types of cancer. The company focuses on identifying biomarkers that enable accurate and reliable diagnosis. The tests developed by OncoCyte Corp can be used for both early detection and monitoring of cancer patients. OncoCyte Corp is divided into several divisions, each specialized in developing products for specific types of cancer. These divisions include breast cancer, lung cancer, bladder cancer, and ovarian cancer. Each division is led by an expert team with extensive knowledge and experience in the respective area. One of the key products of OncoCyte Corp is the DetermaRx™ test, specifically developed for lung cancer. This test identifies specific biomarkers that provide a prognosis regarding the response to chemotherapy. The DetermaRx™ test is currently in clinical trials and could be used in the future to aid in the decision-making process for selecting the appropriate treatment method for lung cancer patients. Another product of OncoCyte Corp is the DetermaDx™ test, specifically developed for the early detection of breast cancer. This test utilizes a combination of biomarker-based tests and imaging techniques to detect cancer cells at an early stage. The DetermaDx™ test is currently undergoing validation and could potentially become a standard diagnosis for breast cancer in the future. OncoCyte Corp has also formed several partnerships with pharmaceutical and diagnostic companies to promote the development and commercialization of its products. One such partnership exists with Life Technologies Corporation, a globally leading company in the field of diagnostics and analytics. OncoCyte Corp strives to develop and bring to market innovative solutions for cancer diagnosis. With its vast resources and experienced team of scientists, the company has the potential to change the way cancer is diagnosed and treated. OncoCyte is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about OncoCyte Stock
What is the dividend yield of OncoCyte?
The current dividend yield of OncoCyte is .
When does OncoCyte pay dividends?
OncoCyte pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of OncoCyte?
OncoCyte paid dividends every year for the past 0 years.
What is the dividend of OncoCyte?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is OncoCyte located?
OncoCyte is assigned to the 'Health' sector.
Wann musste ich die Aktien von OncoCyte kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of OncoCyte from 6/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/30/2024.
When did OncoCyte pay the last dividend?
The last dividend was paid out on 6/30/2024.
What was the dividend of OncoCyte in the year 2023?
In the year 2023, OncoCyte distributed 0 USD as dividends.
In which currency does OncoCyte pay out the dividend?
The dividends of OncoCyte are distributed in USD.
Andere Kennzahlen von OncoCyte
Our stock analysis for OncoCyte Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OncoCyte Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
